2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome

The Writing Group of 2018 Taiwan Guidelines for the Management of Non ST-segment Elevation Acute Coronary Syndrome

研究成果: 雜誌貢獻文章

8 引文 斯高帕斯(Scopus)

摘要

In Taiwan, the incidence of non-ST segment elevation acute coronary syndrome (NSTE-ACS) continues to increase in recent years. The purpose of this guideline is to help health care professionals in Taiwan to use adequate tests and treatments for management of NSTE-ACS. For rapid diagnosis, in addition to history and physical examination, 0/3 h rapid diagnosis protocol with high sensitivity cardiac troponin assay is recommended in this guideline. Dual antiplatelet and anticoagulation therapies are important parts in the initial treatment. Risk stratification should be performed to identify high risk patients for early coronary angiography. Through evaluation of the coronary anatomy and other clinical factors, the decision for coronary revascularization, either by percutaneous coronary intervention or coronary artery bypass grafting, should be decided by the heart team. The duration of dual antiplatelet therapy should be given for at least 12 months after discharge. Other secondary preventive medications are also recommended for long term use.
原文英語
頁(從 - 到)766-790
頁數25
期刊Journal of the Formosan Medical Association
117
發行號9
DOIs
出版狀態已發佈 - 九月 1 2018

    指紋

ASJC Scopus subject areas

  • Medicine(all)

引用此